文献速递心律失常

infusion needle radiofrequency ablation治疗难治性室性心律失常

Infusion Needle Radiofrequency Ablation for Treatment of Refractory Ventricular Arrhythmias.
PubMed 文献 · J Am Coll Cardiol · 2019-01-01

本研究评估可伸缩27G针头射频消融导管靶向心肌内深部基质的安全性与疗效。31例既往消融失败的室性心律失常患者接受针头消融,26例室速患者中73%可消除至少一种可诱发室速,6个月随访48%无复发、19%改善,并发症包括心包积液和起搏导线脱位,无死亡。

要点

  • 针头射频消融可靶向常规导管无法到达的心肌内深部基质。
  • 既往消融失败的室速患者中73%可消除至少一种可诱发室速。
  • 6个月随访48%无复发、19%改善,并发症可接受且无死亡。

核心结论

  • 对于药物和常规导管消融难治的复发性室性心律失常患者,心肌内针头射频消融可显著控制心律失常且操作风险可接受。

研究设计与样本

  • 多中心(3中心)前瞻性研究,纳入至少一次导管消融失败的持续性室速或非持续性室性心律失常伴左室功能障碍患者。
  • 共31例患者接受针头消融,中位既往消融失败次数为2次,71%为非缺血性心脏病。
  • 目标为持续性单形性室速者26例,其中8例近期室速风暴或需静脉药物,5例为伴心室功能障碍的频繁室性心律失常。

主要发现

  • 每例患者中位接受15个针头消融灶。
  • 26例室速患者中19例(73%)消融后至少一种可诱发室速被消除。
  • 5例非持续性心律失常患者中4例消融后日常心律失常被抑制。
  • 6个月随访时48%患者无心律失常复发,另19%患者改善。
  • 操作相关并发症包括1例心包积液经皮穿刺引流和1例左室起搏导线脱位,无死亡。

临床怎么用

  • 对于常规消融失败的室速患者,可考虑针头射频消融靶向心肌内深部基质。
  • 操作需注意心包积液和起搏导线脱位等并发症的监测与处理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Catheter ablation is effective for eliminating most drug-refractory ventricular arrhythmias (VA). However, a major reason for procedural failure is arrhythmia originating deep within the myocardium where it is inaccessible to conventional endocardial or epicardial approaches. Affected patients have limited therapeutic options. OBJECTIVES: The objective of this study was to assess the safety and outcome of a novel radiofrequency ablation catheter that used an extendable/retractable 27-g needle capable of targeting deep arrhythmia (intramural) substrate. METHODS: Patients who failed at least one prior catheter ablation procedure for sustained ventricular tachycardia (VT) or nonsustained VA with associated left ventricular dysfunction were enrolled at 3 centers. The target was sustained monomorphic VT in 26 patients, including 8 with recent VT storm or VT requiring intravenous medication, and 5 with incessant VA associated with ventricular dysfunction. RESULTS: Needle ablation was performed in 31 patients (median of 2 failed prior ablation procedures; 71% nonischemic heart disease). After a median of 15 needle lesions/patient, ablation abolished at least 1 inducible VT in 19 of 26 VT patients (73%), and suppressed ambient arrhythmia in 4 of 5 nonsustained arrhythmia patients. At the 6-month follow-up, 48% of patients were free of recurrent arrhythmia and another 19% were improved. Procedure-related complications included a single pericardial effusion treated with percutaneous drainage and a left ventricular pacing lead dislodgement with no deaths. CONCLUSIONS: In patients with recurrent ventricular arrhythmias refractory to medications and conventional catheter ablation, intramural needle radiofrequency ablation offers significant arrhythmia control with an acceptable procedural risk.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Stevenson WG, Tedrow UB, Reddy V, et al. Infusion Needle Radiofrequency Ablation for Treatment of Refractory Ventricular Arrhythmias. J Am Coll Cardiol. 2019. PMID: 30922472. doi:10.1016/j.jacc.2018.12.070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。